NewsRoom Articles - Page 1314 of 1389

MondayJan 30, 2017 2:30 pm

Anavex Life Sciences Corp. (NASDAQ: AVXL) Starts Presentation at NobleCon13

Anavex Life Sciences (NASDAQ: AVXL) is a clinical-stage biopharmaceutical company engaged in the development of drug candidates for the treatment of pain, Alzheimer’s disease, other central nervous system diseases, and various cancers. The company’s lead drug candidates include ANAVEX 2-73, a phase IIa clinical trial for the treatment of Alzheimer’s disease; also in preclinical stage to treat Parkinson’s disease. Its preclinical drug candidates include ANAVEX 3-71, which uses ligands that activate sigma-1 and M1 muscarinic receptors to treat Alzheimer’s disease; ANAVEX 1-41, a sigma-1 agonist that protects nerve cells from degeneration or death; ANAVEX 1037 for the treatment of prostate…

MondayJan 30, 2017 2:30 pm

OptimizeRx Corp. (OPRX) Starts Presentation at NobleCon13

OptimizeRx (OTC: OPRX) provides technology solutions for the health care industry. The company offers pharmaceutical manufacturers a direct-to-consumer and/or direct to physician channel for communicating and promoting the company’s products. Its products include SampleMD, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through EMR or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies. For more information, visit the company’s website at www.optimizerx.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full…

MondayJan 30, 2017 2:30 pm

RLJ Entertainment, Inc. (NASDAQ: RLJE) Starts Presentation at NobleCon13

RLJ Entertainment (NASDAQ: RLJE) is an entertainment content distribution company primarily in North America, the United Kingdom, and Australia. The company’s titles are distributed in multiple formats including broadcast television (including satellite and cable), theatrical and non-theatrical, DVD, Blu-Ray, digital download, and digital streaming. It owns the OTT branded channels, Acorn TV (British TV) and UMC (Urban Movie Channel). The company targets distinct, premium audiences and urban niche audiences. It grows its proprietary digital channels through development, acquisition, and distribution of exclusive rights of program franchises and feature film content. Through Acorn Media Enterprises, its UK development arm, RLJE owns…

MondayJan 30, 2017 2:30 pm

SeaChange International, Inc. (NASDAQ: SEAC) Starts Presentation at NobleCon13

SeaChange (NASDAQ: SEAC) provides multiscreen video products and services that facilitate the aggregation, licensing, management and distribution of video and television advertising content to cable system operators, satellite operators, and telecommunications and media companies worldwide. The company offers multiscreen video products, including SeaChange Adrenalin, a multiscreen back office platform that enables service providers to manage, monetize and deliver a seamless viewing experience across televisions, personal computers (PCs), tablets, smart phones, and other IP-enabled devices; and SeaChange AssetFlow, which is used to receive, manage, and publish content for on-demand viewing on televisions, tablets, PCs and other consumer devices. For more information,…

MondayJan 30, 2017 2:30 pm

Cellectar Biosciences, Inc. (NASDAQ: CLRB) Starts Presentation at NobleCon13

Cellectar Biosciences (NASDAQ: CLRB) is engaged in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate currently being evaluated in a phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under pre-clinical investigation for the treatment of micrometastatic disease ; CLR 124, a cancer-targeting positron emission tomography (PET) imaging PDC for the selective detection of tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting NIR-fluorophore optical imaging PDC for intraoperative tumor…

MondayJan 30, 2017 2:27 pm

How will Time’s Adelphic acquisition affect the Ad Tech Industry?

Time’s Adelphic acquisition may signal the beginning of a new Ad Tech arms race Companies mentioned in this article: Time, Inc. (NYSE: TIME), Social Reality, Inc. (NASDAQ: SRAX), Adobe Systems, Inc. (NASDAQ: ADBE), Facebook (NASDAQ: FB), Alphabet (NASDAQ: GOOG) and Yahoo (NASDAQ: YHOO) When Time, Inc. (NYSE: TIME) acquired Viant, a data-centric marketing company, last year, many observers wondered just how it planned on monetizing the 1 billion, plus, strong registered user database, but its recently announced plans to acquire Adelphic just filled in the gaps. Adelphic is an innovative demand-side platform (DSP) cross-channel programmatic advertising platform provider, which includes…

MondayJan 30, 2017 2:00 pm

Innodata, Inc. (NASDAQ: INOD) Starts Presentation at NobleCon13

Innodata (NASDAQ: INOD) provides technology solutions and services worldwide, operating through three segments: Content Services (CS), Innodata Advanced Data Solutions (IADS), and Media Intelligence Solutions (MIS). The CS segment produces and distributes e-books, develops new digital information products, and provides operational support services for existing digital information products and systems, including content aggregation, extraction, encoding, indexing and abstracting, fabrication, and distribution. The IADS segment offers services that enable clients in the financial services, insurance, medical and healthcare sectors to enhance decision-support through digital technologies. For more information, visit the company’s website at www.innodata.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

MondayJan 30, 2017 2:00 pm

Salem Media Group (NASDAQ: SALM) Starts Presentation at NobleCon13

Salem Media (NASDAQ: SALM) operates as a multi-media company in the United States. The company owns and operates radio networks, which produce and distribute talk, news and music programming to radio stations in the United States, as well as sells commercial airtime to national advertisers and independent radio station affiliates. It also provides Christian and conservative-themed content, audio and video streaming, and other resources digitally through Christian content websites, such as OnePlace.com, Christianity.com, Crosswalk.com, GodVine.com, Jesus.org, and BibleStudyTools.com; and conservative opinion Websites, such as Townhall.com, HotAir.com, Twitchy.com, HumanEvents.com, and RedState.com. For more information, visit the company’s website www.salem.cc. About NetworkNewsWire…

MondayJan 30, 2017 2:00 pm

Great Panther Silver Limited (NYSE: GPL) Starts Presentation at NobleCon13

Great Panther Silver (NYSE: GPL) is a primary silver mining and exploration company listed on the Toronto Stock Exchange trading under the symbol GPR, and on the NYSE MKT trading under the symbol GPL. Great Panther's current activities are focused on the mining of precious metals from its two wholly-owned operating mines in Mexico: the Guanajuato Mine Complex, which includes the San Ignacio Mine, and the Topia Mine in Durango. In addition, the company has recently signed an agreement to acquire a 100% interest in the Coricancha Mine Complex in the central Andes of Peru. For more information, visit the…

MondayJan 30, 2017 2:00 pm

Eyegate Pharmaceuticals, Inc. (NASDAQ: EYEG) Starts Presentation at NobleCon13

Eyegate Pharmaceuticals (NASDAQ: EYEG) is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and disorders of the eye. EGP-437, the company’s first product in clinical trials, incorporates a reformulated topically active corticosteroid that is delivered into the ocular tissues through EyeGate’s proprietary innovative drug delivery system, the EyeGate® II Delivery System. In addition, the company is developing, through its wholly owned Jade subsidiary, products using cross-linked thiolated carboxymethyl hyaluronic acid (“CMHA-S”), a modified form of the natural polymer hyaluronic acid (HA), which possesses unique physical and chemical properties such as hydration and healing properties.…